244 related articles for article (PubMed ID: 36558408)
1. Old but Fancy: Curcumin in Ulcerative Colitis-Current Overview.
Pituch-Zdanowska A; Dembiński Ł; Banaszkiewicz A
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558408
[TBL] [Abstract][Full Text] [Related]
2. Use of Curcumin in Achieving Clinical and Endoscopic Remission in Ulcerative Colitis: A Systematic Review and Meta-analysis.
Iqbal U; Anwar H; Quadri AA
Am J Med Sci; 2018 Oct; 356(4):350-356. PubMed ID: 30360803
[TBL] [Abstract][Full Text] [Related]
3. [Curcumin add-on therapy for ulcerative colitis].
Salomon N; Lang A; Gamus D
Harefuah; 2015 Jan; 154(1):56-8, 66. PubMed ID: 25796678
[TBL] [Abstract][Full Text] [Related]
4. Curcumin for maintenance of remission in ulcerative colitis.
Kumar S; Ahuja V; Sankar MJ; Kumar A; Moss AC
Cochrane Database Syst Rev; 2012 Oct; 10():CD008424. PubMed ID: 23076948
[TBL] [Abstract][Full Text] [Related]
5. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Andoh A; Tsujikawa T; Fujiyama Y; Mitsuyama K; Sata M; Yamada M; Iwaoka Y; Kanke K; Hiraishi H; Hirayama K; Arai H; Yoshii S; Uchijima M; Nagata T; Koide Y
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300
[TBL] [Abstract][Full Text] [Related]
6. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study.
Singla V; Pratap Mouli V; Garg SK; Rai T; Choudhury BN; Verma P; Deb R; Tiwari V; Rohatgi S; Dhingra R; Kedia S; Sharma PK; Makharia G; Ahuja V
J Crohns Colitis; 2014 Mar; 8(3):208-14. PubMed ID: 24011514
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Curcumin as Adjuvant Therapy to Induce or Maintain Remission in Ulcerative Colitis Patients: an Evidence-based Clinical Review.
Simadibrata M; Halimkesuma CC; Suwita BM
Acta Med Indones; 2017 Oct; 49(4):363-368. PubMed ID: 29348389
[TBL] [Abstract][Full Text] [Related]
8. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700
[TBL] [Abstract][Full Text] [Related]
9. Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis.
Wang Y; Tang Q; Duan P; Yang L
Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):476-482. PubMed ID: 30111198
[TBL] [Abstract][Full Text] [Related]
10. Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study.
Suskind DL; Wahbeh G; Burpee T; Cohen M; Christie D; Weber W
J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):277-9. PubMed ID: 23059643
[TBL] [Abstract][Full Text] [Related]
11. [Second Korean Guideline for the Management of Ulcerative Colitis].
Choi CH; Moon W; Kim YS; Kim ES; Lee BI; Jung Y; Yoon YS; Lee H; Park DI; Han DS;
Korean J Gastroenterol; 2017 Jan; 69(1):1-28. PubMed ID: 28135789
[TBL] [Abstract][Full Text] [Related]
12. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
13. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.
Coelho MR; Romi MD; Ferreira DMTP; Zaltman C; Soares-Mota M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751776
[TBL] [Abstract][Full Text] [Related]
14. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
Cohen RD; Woseth DM; Thisted RA; Hanauer SB
Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
[TBL] [Abstract][Full Text] [Related]
16. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
[TBL] [Abstract][Full Text] [Related]
17. Mesalamine in the treatment and maintenance of remission of ulcerative colitis.
Ham M; Moss AC
Expert Rev Clin Pharmacol; 2012 Mar; 5(2):113-23. PubMed ID: 22390554
[TBL] [Abstract][Full Text] [Related]
18. Mesalamine in the Initial Therapy of Ulcerative Colitis.
Chibbar R; Moss AC
Gastroenterol Clin North Am; 2020 Dec; 49(4):689-704. PubMed ID: 33121689
[TBL] [Abstract][Full Text] [Related]
19. Curcumin for maintenance therapy in ulcerative colitis.
Moss AC
Clin Gastroenterol Hepatol; 2007 May; 5(5):642; author reply 642. PubMed ID: 17478350
[No Abstract] [Full Text] [Related]
20. [Ulcerative colitis and thrombocytopenia: a clinical case of fortuitous association?].
Braucci S; Trappolini F; Angrisani L; Luberti E; Clarice A; Proietta M; Pisani D; Trappolini M
Clin Ter; 2007; 158(1):27-30. PubMed ID: 17405657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
